文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

急诊成人脓毒症限制性液体治疗与标准治疗(REFACED):多中心随机可行性试验

Restrictive fluids versus standard care in adults with sepsis in the emergency department (REFACED): A multicenter, randomized feasibility trial.
PubMed 文献 · Acad Emerg Med · 2022-08-05
一句话结论在无休克的急诊脓毒症成人中,24小时限制性晶体液方案可行,使24小时晶体液量较标准治疗减少约801 ml,不良事件无差异。

REFACED Sepsis为研究者发起的多中心、随机、开放标签可行性试验,将急诊无休克的脓毒症成人分配至24小时限制性晶体液治疗或标准治疗,限制组仅在出现预设低灌注标准时允许液体推注。主要终点为随机化后24小时静脉晶体液总量:限制组562±1076 ml vs 标准治疗组1370±1438 ml(平均差-801 ml,95%CI -1257至-345 ml,p=0.001)。限制组21例(34%)发生方案违背。两组不良事件、机械通气或血管升压药使用、急性肾衰竭、住院时间及死亡率均无差异。作者认为,以患者为中心结局为目标的未来试验似乎可行。

要点

  • 急诊无休克脓毒症成人随机接受24小时限制性晶体液方案,24小时晶体液量562±1076 ml vs 标准治疗1370±1438 ml,平均差-801 ml(95%CI -1257至-345 ml,p=0.001)。
  • 限制组液体推注仅允许在出现预设低灌注标准时进行,标准治疗由治疗团队酌情决定。
  • 限制组21例(34%)发生方案违背。
  • 两组不良事件、机械通气或血管升压药使用、急性肾衰竭、住院时间或死亡率均无差异。
  • 符合全部纳入标准且无排除标准的合格患者中32%(95%CI 28%-37%)被纳入。

适用人群与场景

  • 急诊就诊的成人脓毒症患者,且无休克。

处置流程与药物剂量

  • 限制性晶体液组:24小时内限制性晶体液静脉给药,液体推注仅在出现预设低灌注标准时允许。
  • 标准治疗组:液体治疗由治疗团队酌情决定。

研究设计与关键结果

  • 研究设计:研究者发起的多中心、随机、开放标签可行性试验,纳入123例患者(限制性晶体液组61例,标准治疗组62例)进行主要分析。
  • 主要终点:随机化后24小时静脉晶体液总量,限制性晶体液组562±1076 ml vs 标准治疗组1370±1438 ml,平均差-801 ml(95%CI -1257至-345 ml,p=0.001)。
  • 可行性:符合全部纳入标准且无排除标准的合格患者中32%(95%CI 28%-37%)被纳入;限制性晶体液组21例(34%)发生方案违背。
  • 次要终点:两组不良事件、机械通气或血管升压药使用、急性肾衰竭、住院时间或死亡率均无差异。

证据类型、等级与局限

  • 证据类型:多中心、随机、开放标签可行性试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,以患者为中心结局为目标的未来试验似乎可行。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Fluid treatment in sepsis is a challenge and clinical equipoise exists regarding intravenous (IV) volumes. We aimed to determine whether a 24-h protocol restricting IV fluid was feasible in adult patients with sepsis without shock presenting to the emergency department (ED).

METHODS: The REFACED Sepsis trial is an investigator-initiated, multicenter, randomized, open-label, feasibility trial, assigning sepsis patients without shock to 24 h of restrictive, crystal IV fluid administration or standard care. In the IV fluid restriction group fluid boluses were only permitted if predefined criteria for hypoperfusion occurred. Standard care was at the discretion of the treating team. The primary outcome was total IV crystalloid fluid volumes at 24 h after randomization. Secondary outcomes included total fluid volumes, feasibility measures, and patient-centered outcomes.

RESULTS: We included 123 patients (restrictive 61 patients and standard care 62 patients) in the primary analysis. A total of 32% (95% confidence interval [CI] 28%-37%) of eligible patients meeting all inclusion criteria and no exclusion criteria were included. At 24 h, the mean (±SD) IV crystalloid fluid volumes were 562 (±1076) ml versus 1370 (±1438) ml in the restrictive versus standard care group (mean difference -801 ml, 95% CI -1257 to -345 ml, p = 0.001). Protocol violations occurred in 21 (34%) patients in the fluid-restrictive group. There were no differences between groups in adverse events, use of mechanical ventilation or vasopressors, acute kidney failure, length of stay, or mortality.

CONCLUSIONS: A protocol restricting IV crystalloid fluids in ED patients with sepsis reduced 24-h fluid volumes compared to standard care. A future trial powered toward patient-centered outcomes appears feasible.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Jessen MK, Andersen LW, Thomsen MH, et al. Restrictive fluids versus standard care in adults with sepsis in the emergency department (REFACED): A multicenter, randomized feasibility trial. Acad Emerg Med. 2022. PMID: 35652491. doi:10.1111/acem.14546

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。